Health
Hope grows for blood cancer patients, as cell therapy firm’s key trial succeeds – The Times of Israel
Gamida Cell shares surge after results of key trial show flagship drug results in faster blood count recovery, fewer bacterial and viral infections after bone marrow…
Gamida Cell Ltd., a maker of cell and immune therapy technologies, on Wednesday published the results of a key late-stage clinical trial of its flagship drug, which aims to increase the success of bone marrow transplants in blood cancer patients — triggering a surge in its Nasdaq-traded shares.
Gamida’s shares jumped almost 26% on the US exchange Wednesday. The shares have advanced 163% in the past 12 months, leading to a company valuation of $733 million. The firm held its initial public offering…
-
Noosa News19 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News9 hours agoMurray Watt claims Queensland will follow Sussan Ley and ditch net zero by 2050
-
Noosa News17 hours agoQueensland Drug and Alcohol Court provides sentencing options – Proctor